Abhishek Dutta

Prof. Dr. Abhishek Dutta

ECE, University of Connecticut, Storrs, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
RYRongting Yue
Rongting Yue
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
Omics-based approaches have become increasingly influential in identifying disease mechanisms and drug responses. Considering that diseases and drug responses are co-expressed and regulated in the relevant omics data interactions, the traditional way of grabbing omics data from single isolated layers cannot always obtain valuable inference. Also, drugs have adverse effects that may impair patients, and launching new medicines for diseases is costly. To resolve the above difficulties, systems biology is applied to predict potential molecular interactions by integrating omics data from genomic, proteomic, transcriptional, and metabolic layers. Combined with known drug reactions, the resulting models improve medicines’ therapeutical performance by re-purposing the existing drugs and combining drug molecules without off-target effects. Based on the identified computational models, drug administration control laws are designed to balance toxicity and efficacy. This review introduces biomedical applications and analyses of interactions among gene, protein and drug molecules for modeling disease mechanisms and drug responses. The therapeutical performance can be improved by combining the predictive and computational models with drug administration designed by control laws. The challenges are also discussed for its clinical uses in this work.

4 June 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
The waves of COVID-19 infections driven by its variants continue to nullify the success we achieved through efficacious vaccines, social restrictions, testing and quarantine policies. This paper models the two major variants-driven waves by two sets of susceptible-infected-quarantined-recovered-vaccinated-deceased coupled dynamics that are modulated by the three main interventions: vaccination, quarantine and restrictions. This $$SI^2Q^2R^2VD$$ S I 2 Q 2 R 2 V D system is used to demonstrate that the second major novel coronavirus wave in the US is caused by the delta variant and the corresponding rapid surge in infectious cases is driven by the unvaccinated pool of the populace. Next, a feedback control based planned vaccination strategy is derived and is shown to be able to suppress the surge in infections effectively.

7 August 2019 in IEEE Transactions on Systems, Man, and Cybernetics: Systems
Verified
Journal Article
Closed access
DFDongfei Fu
Dongfei Fu
HZHai-Tao Zhang
Hai-Tao Zhang
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
GCGuanrong Chen
Guanrong Chen
Effective supply chain management is a crucial competency for modern enterprises, but the issue has not been systemically addressed. To this end, we develop a distributed model predictive control (DMPC) approach with minimal information exchange and communication to handle supply chain operations and management. Therein, each decision maker relies on an agent with local information and they are collaborating to minimize a global cost function that measures the control performance of the entire network. The information flow topology is utilized to sequentially solve the DMPC optimization problem. The control sequence of downstream nodes is predicted with information transmitted to the upstream nodes. The stability of the proposed DMPC scheme is provably guaranteed. Finally, a numerical example is presented to verify the effectiveness of the proposed scheme.

18 March 2024 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
YHYen-Che Hsiao
Yen-Che Hsiao
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
Dynamic disease pathways are a combination of complex dynamical processes among bio-molecules in a cell that leads to diseases. Network modeling of disease pathways considers disease-related bio-molecules (e.g. DNA, RNA, transcription factors, enzymes, proteins, and metabolites) and their interaction (e.g. DNA methylation, histone modification, alternative splicing, and protein modification) to study disease progression and predict therapeutic responses. These bio-molecules and their interactions are the basic elements in the study of the misregulation in the disease-related gene expression that lead to abnormal cellular responses. Gene regulatory networks, cell signaling networks, and metabolic networks are the three major types of intracellular networks for the study of the cellular responses elicited from extracellular signals. The disease-related cellular responses can be prevented or regulated by designing control strategies to manipulate these extracellular or other intracellular signals. The paper reviews the regulatory mechanisms, the dynamic models, and the control strategies for each intracellular network. The applications, limitations and the prospective for modeling and control are also discussed.

22 May 2019 in IEEE Pulse
Verified
Journal Article
Closed access
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
A tiny cockroach no bigger than a large paper clip scurries across the floor of my bio-engineering lab at the University of Connecticut, Mansfield, CT, USA. It is a robot-roach hybrid, a hardwired biological insect, a cyborg if you will, and its future high-tech brethren may one day save your life. The use of insects as platforms for small robots has an incredible number of useful applications from search and rescue to national defense.

27 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Abhishek DuttaAbhishek Dutta
Abhishek Dutta
COVID-19 together with variants have caused an unprecedented amount of mental and economic turmoil with ever increasing fatality and no proven therapies in sight. The healthcare industry is racing to find a cure with multitude of clinical trials underway to access the efficacy of repurposed antivirals, however the much needed insights into the dynamics of pathogenesis of SARS-CoV-2 and corresponding pharmacology of antivirals are lacking. This paper introduces systematic pathological model learning of COVID-19 dynamics followed by derivative free optimization based multi objective drug rescheduling. The pathological model learnt from clinical data of severe COVID-19 patients treated with remdesivir could additionally predict immune T cells response and resulted in a dramatic reduction in remdesivir dose and schedule leading to lower toxicities, however maintaining a high virological efficacy.